Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for STAA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 8.62%
March 31, 2026 5.57%
December 31, 2025 -31.68%
September 30, 2025 9.38%
June 30, 2025 -37.93%
March 31, 2025 -127.3%
December 31, 2024 -69.92%
September 30, 2024 11.27%
June 30, 2024 7.45%
March 31, 2024 -4.32%
December 31, 2023 10.17%
September 30, 2023 6.00%
June 30, 2023 6.57%
March 31, 2023 3.69%
December 31, 2022 9.14%
September 30, 2022 13.49%
June 30, 2022 16.08%
March 31, 2022 15.19%
December 31, 2021 8.34%
September 30, 2021 10.32%
June 30, 2021 13.74%
March 31, 2021 9.84%
December 31, 2020 7.23%
September 30, 2020 8.27%
June 30, 2020 -3.33%
Date Value
March 31, 2020 -0.38%
December 31, 2019 16.41%
September 30, 2019 6.11%
June 30, 2019 9.87%
March 31, 2019 4.20%
December 31, 2018 3.51%
September 30, 2018 4.59%
June 30, 2018 5.40%
March 31, 2018 2.15%
December 31, 2017 -0.56%
September 30, 2017 5.00%
June 30, 2017 -4.43%
March 31, 2017 -10.83%
December 31, 2016 -0.75%
September 30, 2016 -8.87%
June 30, 2016 -10.22%
March 31, 2016 -41.73%
December 31, 2015 -4.05%
September 30, 2015 -9.34%
June 30, 2015 -8.57%
March 31, 2015 -11.99%
December 31, 2014 -15.34%
September 30, 2014 -14.88%
June 30, 2014 -8.92%
March 31, 2014 -6.74%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 28.46%
Enovis Corp. -0.18%
Stryker Corp. 19.37%
Zimmer Biomet Holdings, Inc. 9.17%
Edwards Lifesciences Corp. 13.87%